Authors/Disclosures
|
William A. Kilgo, MD, FAAN
|
Dr. Kilgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kilgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Kilgo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Kilgo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. |
|
Rohini D. Samudralwar, MD
(The University of Pennsylvania)
|
Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America. |
|
Raja S. Boddepalli, MD
|
No disclosure on file |
|
Joseph S. Kass, MD, JD, FAAN
(Baylor College of Medicine)
|
Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care. |
|
Steven T. Bellows, MD
(Baylor College of Medicine)
|
The institution of Dr. Bellows has received research support from Takeda Pharmaceuticals. The institution of Dr. Bellows has received research support from Sage Therapeutics. The institution of Dr. Bellows has received research support from Bukwang Pharmaceutical . The institution of Dr. Bellows has received research support from AbbVie. |
|
|
No disclosure on file |